Osaic Holdings’s Vivos Therapeutics VVOS Stock Holding History

Osaic Holdings’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$516	Hold	1,143	–	–	﹤0.01%	7641
2026 Q1	$1.35K	Hold	1,143	–	–	﹤0.01%	7173
2025 Q4	$2.32K	Sell	1,143 -5,410	-83%	-$13.4K	﹤0.01%	7050
2025 Q3	$20.7K	Buy	6,553 +5,760	+726%	+$26.1K	﹤0.01%	5907
2025 Q2	$2.5K	Buy	793 +593	+297%	+$1.5K	﹤0.01%	6851
2025 Q1	$570	Sell	200 -393	-66%	-$1.54K	﹤0.01%	6966
2024 Q4	$2.54K	Sell	593 -775	-57%	-$2.59K	﹤0.01%	6508
2024 Q3	$3.57K	Buy	1,368 +470	+52%	+$1.23K	﹤0.01%	6373
2024 Q2	$1.99K	Buy	+898	New	+$2.19K	﹤0.01%	6597
2023 Q3	–	Sell	-40	Closed	-$510	–	7551
2023 Q2	$510	Buy	+40	New	+$392	﹤0.01%	7049

Other funds holding VVOS

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CWM

Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Osaic Holdings's VVOS Position: Q2 2026 in Review

Osaic Holdings held its Vivos Therapeutics (VVOS) position steady in Q2 2026 at 1,143 shares worth $516. The position accounts for ﹤0.01% of the portfolio, ranked #7641.

Osaic Holdings first reported a position in VVOS in Q2 2023 and has held it in 10 quarters since. The position peaked at $20.7K in Q3 2025. 22 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

Osaic Holdings held 1,143 shares of Vivos Therapeutics worth $516 as of Q2 2026.
Osaic Holdings left its Vivos Therapeutics share count unchanged in Q2 2026.
Vivos Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7641 holding.
Osaic Holdings first reported a position in Vivos Therapeutics in Q2 2023 and has held it in 10 quarters since.
Osaic Holdings's Vivos Therapeutics position peaked at $20.7K in Q3 2025.
22 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.